Emerging research indicates that retatrutide, a dual-action medication, may revolutionize the treatment of excess weight . Differing from many current weight loss therapies , retatrutide works as both a GLP-1 receptor and a GIP receptor , affecting various factors involved in cravings regulation and glucose optimization. Initial patient studies re